Clinical Trial Update: Persisting Effects of Psilocybin [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial assessing persisting effects of psilocybin in healthy volunteers; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Johns Hopkins University | Conditions: Healthy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-09-10